Jpmorgan Chase & Co »

Madrigal Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Madrigal Pharmaceuticals shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Madrigal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Madrigal Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Madrigal Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $11M 47k 231.38
2023-09-30 $11M 74k 146.04
2023-06-30 $97M 419k 231.00
2023-03-31 $102M 421k 242.26
2022-12-31 $2.9M 10k 290.30
2019-03-31 $3.4M 27k 125.26
2018-12-31 $1.0M 9.0k 112.67

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Nvidia Corporation Common (NVDA)
Meta Platforms Common (META)
Unitedhealth Group Common (UNH)
Vanguard Total Intl Bond Etf Fund (BNDX)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Abbvie Common (ABBV)
Vanguard Total Bond Market Fund (BND)
Tesla Common (TSLA)

View all positions for Jpmorgan Chase & Co

Top funds holding Madrigal Pharmaceuticals

Jane Street
Simplex Trading
Jpmorgan Chase & Co
Advisor Group Holdings

View all funds holding Madrigal Pharmaceuticals